CHU De Dijon
- Address
- 14 rue Gaffarel, Department of Infectious Diseases, Hall C, 21000 Dijon, France
CHU De Dijon - Infectious Disease Research Center
CHU De Dijon is a prominent clinical research center with specialized expertise in infectious diseases and neurological infections. The center demonstrates particular strength in developing innovative treatment approaches for complex central nervous system infections, focusing on optimizing antibiotic therapy strategies to improve patient outcomes while reducing the burden of intravenous treatments.
- Central nervous system infections and brain abscess treatment protocols
- Antibiotic therapy optimization and oral-to-IV conversion strategies
- Non-inferiority trial design for infectious disease management
The center is actively involved in groundbreaking research investigating partial oral antibiotic treatment for bacterial brain abscess, a serious condition requiring prolonged antimicrobial therapy. Through rigorous randomised controlled trials, CHU De Dijon contributes to evidence-based practice by evaluating whether oral antibiotics can provide comparable efficacy to traditional intravenous regimens, potentially improving patient quality of life and reducing healthcare costs without compromising clinical outcomes.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 2 therapeutic areas and 15 of 20 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Aalborg University Hospital1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in CHU De Dijon
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Clindamycin Hydrochloride and Drug Combination on 90-Day Mortality in Patients with Staphylococcus aureus Bacteremia | Universitair Medisch Centrum Utrecht | Phase III | Recruiting | Oct 2023 | — |
IMP list
lock Showing 1 of 20 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Amoxicillin | 2 | Unknown | 2021-05-02 | 2023-10-26 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.